StockClub
TLXTelix Pharmaceuticals Limited$ --
Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

TLX

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
1,205M AUD
YoY +53.9%

Operating Income

bar_chart
27M AUD
YoY -67.6%

Net Income

verified
-11M AUD
YoY -121.4%

EPS

pie_chart
-0.03AUD
YoY -121.1%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress-418.3%Below Target
Revenue Progress1.2B
Revenue Forecast1.2B
Net Income Progress-10.7M
Net Income Forecast2.6M

Income Statement Details

Item
1999
2000
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
1,205
565
640
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
257
0
357
1,179
27
Interest expense
Income before tax
Income tax expense
Net income
55
-8
3
-11

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.